abstract |
Embedded image The compounds of formula (I) are useful in the treatment of conditions or diseases that are prevented or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions containing histamine-3 receptor ligands, methods of using such compounds and compositions, and processes for preparing compounds within the scope of formula (I). |